COMMUNIQUÉS West-GlobeNewswire

Sarepta Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference

05/02/2018 - 14:30

CAMBRIDGE, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]

BriaCell Presenting at Upcoming Cancer Conference

05/02/2018 - 14:30

BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]

Minerva Neurosciences Names Remy Luthringer as Executive Chairman and William Doyle as Lead Independent Director

05/02/2018 - 14:30

WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today [...]

EyeGate Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery

05/02/2018 - 14:30

WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies [...]

Acer Therapeutics Expands Management Team with the Appointment of Three Executives and One New Key Hire

05/02/2018 - 14:30

Company appoints new VPs of Clinical Science, Manufacturing, and Finance and hires new Senior Director of Marketing New hires support Acer’s progression from development to potential commercialization of EDSIVO TM [...]

Progenics Pharmaceuticals to Present at the 2018 BIO CEO & Investor Conference

05/02/2018 - 14:30

NEW YORK, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced [...]

BeyondSpring Summarizes Key Messages from KOL Call regarding Lead Asset Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia

05/02/2018 - 14:30

NEW YORK , Feb. 05, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical-stage biopharmaceutical company focused on the development of transforming immuno-oncology cancer therapies, today [...]

Anthera Concludes Last Patient Visit in the Phase 3 RESULT Clinical Study of Sollpura

05/02/2018 - 14:30

HAYWARD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) is pleased to announce that the final patient has completed the last visit in the primary treatment phase of RESULT, a [...]

Canada House Wellness Group Now Included in the Emerging Marijuana ETF

05/02/2018 - 14:24

TORONTO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that it has been included in an Electronic Trading Fund “ETF” the Emerging [...]

ICYMI - Premier Biomedical CEO Interviewed on Fox Business “New To The Street” Program

05/02/2018 - 14:21

JACKSON CENTER, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) President and CEO, William A. Hartman was interviewed by host, Ken Evseroff, on the program “New To The Street”, which aired on [...]

Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd.

05/02/2018 - 14:18

SHANGHAI, China and CUPERTINO, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG ) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the development of immunotherapies [...]

Cancer Genetics, Inc. Chief Executive Officer Steps Down

05/02/2018 - 14:12

• Board Appoints COO, Jay Roberts, Interim Chief Executive Officer RUTHERFORD, N.J., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ) an emerging leader in enabling precision medicine for oncology [...]

Sorrento Therapeutics, Inc. Chairman/CEO letter to stockholders

05/02/2018 - 14:01

SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Dear Sorrento Stockholders, Since its inception in 2006, Sorrento Therapeutics, Inc. (“Sorrento”) has continued to evolve as a dynamic, forward-focused biopharmaceutical [...]

BIOLIFE4D Signs Laboratory Service Agreement with Northwestern University

05/02/2018 - 14:01

CHICAGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has signed a Laboratory Service [...]

Vericel to Present at the BIO CEO & Investor Conference

05/02/2018 - 14:00

CAMBRIDGE, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]

Fibrocell Announces Submission of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma

05/02/2018 - 14:00

EXTON, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]

Bio-Path Holdings Appoints Paul Aubert to its Board of Directors

05/02/2018 - 14:00

HOUSTON, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]

Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) 2018 Annual Meeting

05/02/2018 - 14:00

ROCKVILLE, Md., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, [...]

David Taing, MD, DC, CAQSM is Elected to the American Health Council’s Board of Physicians

05/02/2018 - 14:00

NEW YORK, Feb. 05, 2018 (GLOBE NEWSWIRE) -- The American Health Council has elected David Taing, MD, DC, CAQSM, to its Board of Physicians. He is currently a Hospital-Employed Physician and Medical Director of two [...]